β-casomorphin induces Fos-like immunoreactivity in discrete brain regions relevant to schizophrenia and autism

Autism

Volumn 3, Issue 1, 1999, Pages 67-83

  Sun, Zhongjie ^b   Cade, J Robert ^a   Fregly, Melvin J ^b   Privette, R Malcolm ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Autism; Brain; Casomorphin; Fos; Gene; Naloxone; Schizophrenia

Indexed keywords

BETA CASOMORPHINE; NALOXONE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BEHAVIOR; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; BRAIN REGION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DELUSION; DOPAMINERGIC SYSTEM; ENTORHINAL CORTEX; FRONTAL CORTEX; GABAERGIC SYSTEM; HALLUCINATION; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEDIAN RAPHE NUCLEUS; NONHUMAN; NUCLEUS ACCUMBENS; OCCIPITAL CORTEX; ONCOGENE C FOS; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RAT; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SOCIAL ADAPTATION; TEGMENTUM; TEMPORAL CORTEX; URINALYSIS;

EID: 0033037343     PISSN: 13623613     EISSN: None     Source Type: Journal    
DOI: 10.1177/1362361399003001006     Document Type: Article

References (63)

1. ABASSI, Z., GOLOMB, E. & KEISER, H. R. (1992) 'Neutral Endopeptidase Inhibition Increases the Urinary Excretion and Plasma Levels of Endothelin', Metabolism 41: 683-5.
2. ACKER, J. M. (1993) 'Electrophysiological Effects of Putative Autoreceptor-Selective Dopamine Agonists on A10 Dopamine Neurons', J. Pharmacol. Exp. Ther. 265: 963-70.
3. ANDERS, V. N. (1978) 'Ultrastructural Features of Cerebral Synapse in Schizophrenic Patients', Zh. Nevropatol. Psikhiatr. 78: 1065-70.
4. ARNOLD, S. E., HYMAN, B. T. & VAN HORSEN, G. W. (1989) 'Cytoarchitectural Abnormalities of the Entorhinal Cortex in Schizophrenia', Society for Neuroscience Abstracts. 2: 1123.
5. BLAU, N., NIEDERWIESER, A. & SHMERLING, D. H. (1988) 'Peptiduria Presumably Caused by Aminopeptidase Deficiency. A New Inborn Error of Metabolism', J. Inherited Metab. Dis. II. suppl. 2: 240-2.
6. BLEICH, A., BROWN, S. L., KAHN, R. & VAN PRAAG, H. M. (1988) 'The Role of Serotonin in Schizophrenia', Schizophrenia Bulletin 14: 297-315.
7. BOGERTS, B. (1984) 'Zur Neuropathologie der Schizophrenien', Fortschr. Neurol. Psychiat. 52: 428-37.
8. BOGERTS, B., HANTSCH, J. & HERZER, M. (1983) 'A Morphometric Study of the Dopamine Containing Cell Groups in the Mesencephalon of Normals, Parkinson's Patients, and Schizophrenics', Biol. Psychiat. 18: 951-69.
9. BOGERTS, B., MEERTZ, E. & SCHONFELDT-BAUSCH, R. (1985) 'Basal Ganglia and Limbic System Pathology in Schizophrenia', Arch. Gen. Psychiat. 42: 784-91.
10. BRANTL, V., TESCHEMACHER, H., BLASIZ, J., HENSCHEN, A. & LOTTSPEICH, F. (1981) 'Opioid Activities of β-Casomorphins', Life Sciences 28: 1903-9
11. BRAUNIG, P., RAO, M. L. & FIMMERS, R. (1989) 'Blood Serotonin Levels in Suicidal Patients', Acta Psychiat. Scand. 79: 186-9.
12. CADE, R., WAGEMAKER, H., PRIVETTE, R. M., FREGLY, M. J., ROGERS, J. & ORLANDO, J. (1990) 'The Effect of Dialysis and Diet on Schizophrenia', Psychiat: A World Perspective 3: 494-500.
13. CADE, R., PRIVETTE, M., FREGLY, M. J., ROWLAND, N. B., SUN, Z., ZELE, V. & WAGEMAKER, H. (1999) 'Autism and Schizophrenia: Intestinal Disorders', Nutritional Neuroscience, submitted.
14. CASANOVA, M. F., CAROSELLA, N. & KLEINMAN, J. E. (1989a) 'Midbrain Tegmental Pathology in a Case of Childhood Schizophrenia', Biol. Psychiat. 25: 59a.
15. CASANOVA, M. F., HYDE, T., GOLDBERG, T., WEINBERG, D. & KLEINMAN, J. (1989b) Ventral Tegmental Pathology in Schizophrenia. New Research Program and Abstracts. American Psychiatric Association 142nd Annual Meeting, San Francisco (79 pp.).
16. CASANOVA, M. F. , CAROSELLA, N. & KLEINMAN, J. E. (1990) Neuropathological Findings in a Suspected Case of Childhood Schizophrenia', J. Neuropsychiat. Clin. Neurosci. 2: 313-19.
17. CEULEMANS, D. L. S., GELDERS, Y., HOPPENBROUWERS, M. L., REYNTJENS, A. & JANSEN, P.. (1985) 'Effect of Serotonin Antagonism in Schizophrenia: A Pilot Study with Setoperone', Psychopharmacol. 85: 329-32.
18. CHANG, K. J., SU, Y. F., BRENT, D. A. & CHANG, J. K. (1985) 'Isolation of a Specific μ-Opiate Receptor Peptide, Morphiceptin, from an Enzymatic Digest of Milk Proteins', J. Biol. Chem. 260: 9706-12.
19. DAVIS, T. P., SCHOEMAKER, H., COLING, A. & YAMAMURA, H. I. (1983) 'Isolation and Characterization of in vitro Central β-Endorphin Metabolism in Schizophrenia', Proc. West. Pharmacol. Soc. 26: 89-94.
20. D'EUFEMIA, P., CELLI, M., FINOCCHIARO, R., PACIFICO, L., VIOZZI, L., ZACCAGNINI, M., CARDI, E. & GIARDINI, O. (1996) 'Abnormal Intestinal Permeability in Children with Autism', Acta Paediatr. 85: 1076-9.
21. DOHAN, F. C. (1983) 'More on Celiac Disease as a Model for Schizophrenia', Biol. Psychiat. 18: 561-4.
22. DOM, R., SAEDELEER, J., BOGERTS, J. & HOPF, A. (1981) 'Quantitative Cytometric Analysis of Basal Ganglia in Catatonic Schizophrenics', in C. PERRIS, G. STRUWE, & B. JANSSON (eds) Biological Psychiatry, pp. 723-6. New York: Elsevier.
23. DOTY, R. M. (1989) 'Schizophrenia: A Disease of Interhemispheric Processes at Forebrain and Brainstem Levels?', Behav. Brain Res. 34: 1-33.
24. DRYSDALE, A., DEACON, R., LEWIS, P., OLLY, S., ELECTRICWALA, A. & SHERWOOD, R. A. (1982) 'Peptide Containing Fraction of Plasma of Schizophrenic Patients Which Binds to Opiate Receptors and Induces Hyperactivity in Rats', Neurosci. 7: 1567-74.
25. DU VERGLAS, G., BANKS, S. R. & GUYER, K. E. (1988) 'Clinical Effects of Fenfluramine on Children with Autism. Review of the Research', Journal of Autism and Developmental Disorders. 18: 297-308.
26. ELKASHEF, A. M. (1994) 'Basal Ganglia Pathology in Schizophrenia and Tardive Dyskinesia: An MRI Quantitative Study', Am. J. Psychiat. 151: 752-5.
27. EMRICH, H. W., CORDING, C., PIREE, S., KOELLING, A., VON ZERSSEN, D. & HERZ, A. (1977) 'Indication of an Autopsychotic Action of the Opiate Antagonist Naloxone', Pharmacopsychiat. Neuropsychopharmacol. 10: 265-70.
28. FALKAI, P., BOGERTS, B. & ROZUMEK, M. (1988) 'Limbic Pathology in Schizophrenia: The Entorhinal Region, a Morphometric Study', Biol. Psychiat. 24: 515-21.
29. FALLON, J. H., RILEY, J. N. & MOORE, R. Y. (1978) 'Substantia Nigra Neuron: Separate Populations Project to Neostriatum and Allocortex', Neurosci. Lett. 7: 157-62.
30. FUXE, K., HOKFELT, T., JOHANSSON, O., JONSSON, G., LINDBRINK, P. & LJUNGDAHL, A. (1974) 'The Origin of Dopamine Nerve Terminals in Limbic and Frontal Cortex. Evidence for Mesocortico Dopamine Neurons', Brain Res. 82: 349-55.
31. GRUZELIER, J. H. (1993) 'Cerebral Asymmetries and Stimulus Intensity Relationships in EEG Spectra of VEPs in Unmedicated Schizophrenic Patients: Relationship with Active and Withdrawn Syndromes', Int. J. Psychophysiol. 15: 239-46.
32. HOLE, K., BERGSLIEN, H., JORGENSEN, H. A. & BERGE, O. G. (1979) 'A Peptide-Containing Fraction in the Urine of Schizophrenic Patients Which Stimulates Opiate Receptors and Inhibits Dopamine Uptake', Neurosci. 4: 1883-93.
33. IDET, M., GROF, J., MENYHART, J. & PAJOR, A. (1982) 'Elevated Opioid Activity in Sera of Chronic Schizophrenics', Acad Physiol. Acad. Hung. 60: 121-7.
34. JAKOB, H. & BACKMANN, H. (1986) 'Prenatal Developmental Disturbances in the Limbic Allocortex in Schizophrenics', J. Neural Transmission. 65: 303-26.
35. JORGENSEN, H. A. & CAPPELEN, C. (1992) 'Naloxone-Induced Reduction of Schizophrenic Symptoms: A Case Report', Acta Psychiat. Scand. 65: 370-4.
36. KARSON, C. N. (1990) 'Blink Rate in Schizophrenia', Schizophr. Bull. 16: 345-54.
37. LEMAY, M. (1976) 'Morphological Cerebral Asymmetries of Modern Man, Fossil Man, and Non-Human Primates', Ann. N.Y. Acad. Sci. 280: 349-66.
38. LEMAY, M. & KIDA, D. K. (1978) 'Asymmetries of Cerebral Hemispheres on Computed Tomograms', J. Comput. Assist. Tomogr. 2: 470-6.
39. LINDSTROM, L. H., NYBERG, F., TERENIUS, L., BAUER, K., BESEV, G., GUNNE, L. M., LYRENAS, S., WILLDECK-LUND, G. & LINDBERG, B. O. (1984) 'CSF and Plasma β-Casomorphin-Like Opioid Peptides in Postpartum Psychosis', Am. J. Psychiat. 141(9): 1059-66.
40. LINDSTROM, L. H., LYRENAS, S., NYBERG, F. & TERENIUS, L. (1990) 'Beta-Casomorphins in Postpartum Psychosis', in F. NYBERG & V. BRANTL (eds) β-Casomorphins and Related Peptides, pp. 157-62. Uppsala: Fyris Tryck.
41. LINDVALL, O. & BJORKLUND, A. (1974) 'The Organization of Ascending Catecholamine Neuron Systems in the Rat Brain Revealed by the Glyoxylic Acid Fluorescence Method', Acta Physiol. Scand. 412 (suppl): 1-48.
42. MCGEER, P. L. & MCGEER, E. G. (1977) 'Possible Changes in Striatal and Limbic Cholinergic Systems in Schizophrenia', Arch. Gen. Psychiat. 34: 1319-23.
43. MORGAN, L. O. & GREGORY, H. S. (1935) 'Pathological Changes in the Tuber Cinerum in a Group of Psychosis', J. Nerv. Mental Dis. 82: 286-98.
44. MORGAN, U. I. & ;CURRAN, T. (1991) 'Stimulus-Transcription Coupling in the Nervous System: Involvement of the Inducible Proto-Oncogenes Fos and Jun', Ann. Rev. Neurosci. 14: 421-51.
45. OWEN, F., CROW, T. J., POULTER, M., CROSS, A. J., LONGDEN, A. & RILEY, G. J. (1978) 'Increased Dopamine-Receptor Sensitivity in Schizophrenia', Lancet 2: 223-6.
46. PAKKENBERG, B. (1990) 'Pronounced Reduction of Total Neuron Number in Mediodorsal Thalamic Nucleus and Nucleus Accumbens in Schizophrenics', Archives of General Psychiat. 47: 1023-8.
47. PAXINOS, G. & WATSON, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. New York: Academic.
48. PEROUTKA, F. J. & FLIGHT, A. J. (1990) 'Central S-HT Receptors: Functional Correlates and Clinical Relevance, in H. M. VAN PRAAG & S. C. BROWN (eds) The Role of Serotonin in the Psychiatric Disorders. New York: Brunner Mazel.
49. REICHELT, K. L., HOLE, K., HAMBERGER, A., SAELID, G., EDMINSON, P. D., BRAESTRUP, C. B., LINGJAERDE, O., LEDAAL, P. & ORBECK, H. (1981) 'Biologically Active Peptide-Containing Fractions in Schizophrenia and Childhood Autism', in J. B. MARTIN, S. REICHLIN & K. L. BICK (eds) Neurosecretion and Brain Peptides, pp. 627-43. New York: Raven.
50. REICHELT, K. L., EDMINSON, P. D. & TOFT, K. G. (1985) 'Urinary Peptides in Schizophrenia and Depression', Stress Medicine 1: 169-81.
51. REICHELT, K. L., PEDERSEN, O. S., KROGH, M. H. & GJERSTAD, B. T. (1987) 'Chemical Diagnosis, Etiology and Possible Treatment of Schizophrenia', in C. B. DAHL, T. HAUG, M. SVARTBERG, O. LINAKER & L. ERIKSEN (eds) Clinical Research in Psychiatry, pp. 85-101. Trondheim: University of Trondheim Press.
52. REICHELT, K. L., KNIVSBERG, A. M., LIND, G. & NODLAND, M. (1991) 'Probable Etiology and Possible Treatment of Childhood Autism', Brain Dysfunct. 4: 308-19.
53. REICHELT, K. L., KNIVSBERG, A. M., NODLAND, M. & LIND, G. (1994) 'Nature and Consequences of Hyperpeptiduria and Bovine Casomorphins Found in Autistic Syndromes', Dev. Brain Dysfunct. 7: 71-85.
54. SAGAR, S. M., SHARP, F. R. & CURRAN, T. (1988) 'Expression of c-Fos Protein in Brain: Metabolic Mapping at the Cellular Level', Science. 240: 1328-31.
55. SHARP, F. R., SAGAR, S. M., HICKS, K., LOWENSTEIN, D. & HISANAGA, K. (1991) 'C-Fos mRNA, Fos, and Fos-Related Antigen Induction by Hypertonic Saline and Stress', J. Neurosci. 11: 2321-31.
56. SORENSEN, S. M., KEHNE, J. H., FADAYEL, G. M., HUMPHREYS, T. M., KETTELER, H. J., SULLIVAN, C. K., TAYLOR, V. L. & SCHMIDT, C. J. (1993) 'Characterization of the 5-HT Receptor Antagonist MDL 100907 as a Putative Atypical Antipsychotic: Behavioral, Electrophysiological and Neurochemical Studies', J. Pharmacol. Exp. Ther. 266: 684-91.
57. STEVENS, J. R. (1982) 'Neuropathology of Schizophrenia', Arch. Gen. Psychiat. 39: 1131-9.
58. SUN, Z., FREGLY, M. J., ROWLAND, N. E. & CADE, J. R. (1996) 'Comparison of Changes in Blood Pressure and Dipsogenic Responsiveness to Angiotensin II in Male and Female Rats Chronically Exposed to Cold', Physiol. Behav. 60(6): 1543-9.
59. SUZUKI, M., YUASA, S., MURATA, M. & KURACHI, M. (1993) 'Left Superior Temporal Blood Flow Increases in Schizophrenic and Schizophreniform Patients with Auditory Hallucination: A Longitudinal Case Study Using 1231-IMP Spect', Eur. Arch. Psychiat. Clin. Neurosci. 22: 239-46.
60. TANAKA, Y., HAZAMA, H., KAWAHARA, R. & KOBAYASHI, K. (1981) 'Computerized Tomography of the Brain in Schizophrenic Patients', Acta Psychiat. Scand. 63: 191-7.
61. WAGEMAKER, H. & CADE, R. (1977) 'The Use of Hemodialysis on Chronic Schizophrenic Patients', Am. J. Psychiat. 134: 684-5.
62. WATANABE. Y., KOJIMA-KOMATSU, T., IWAKI-EGURA, S. & FUJIMOTO, Y. (1993) 'Increased Excretion of Proline-Containing Peptides in Dipeptidyl Peptidase IV Deficient Rats', Res. Comm. Clin. Pathol. Pharmacol. 81: 323-30.
63. WIEGANT, V. M., VERHOEF, C. J., BURBACH, P. H. & DE WIED, D. (1988) 'Increased Concentration of Alpha-and Gamma-Endorphin in Postmortem Hypothalamic Tissue of Schizophrenic Patients', Life Sci. 42: 1733-42.